Dr. Bussey obtained his B.S. in Pharmacy from the University of Georgia and his Pharm.D. (with concurrent residency in Internal Medicine) from the University of Texas at Austin and the University of Texas Health Science Center in San Antonio. He is a Fellow of the American College of Clinical Pharmacy, the American College of Chest Physicians, and the American Heart Association and its Council on High Blood Pressure Research. He has over 100 publications, is on the editorial board for Pharmacotherapy, and serves as a reviewer for several pharmacy and medical journals. His research is clinically focused and was instrumental in the adoption of the INR for warfarin monitoring in North America. Currently, he is a professor in the College of Pharmacy at the University of Texas at Austin, is president of Genesis Clinical Research in San Antonio, TX, and is Co-founder and Senior Editor of ClotCare Online Resource. Dr. Bussey served on the American College of Chest Physicians Consensus Conference on Antithrombotic Therapy for ten years and on the College of American Pathologists Consensus Conference on Anticoagulation Monitoring. Dr. Bussey is on advisory boards for Sanofi-Aventis Pharmaceuticals, AstraZeneca, and Boehringer-Ingelheim.
William Dager, PharmD, FCSHP, Pharmacist Specialist, University of California, Davis Medical Center
One of the major areas of patient care responsibilities for me has been the management of anticoagulation therapy, primarily in the inpatient setting. This has resulted in dozen of published manuscripts covering a wide number of related issues. I have also represented pharmacy on multi-disciplinary national events, and lectured on optimizing anticoagulation therapy. My practice setting has been highlighted in AJHP and by ACCP. Other related activities include serving as the chair of the editorial advisory board for The Annals of Pharmacotherapy panel on anticoagulation, and authored three chapters in the ASHP textbook on anticoagulation therapy edited by Michael Gulseth.
Other Academic Titles (without pay)
Clinical Professor of Pharmacy, UC San Francisco School of Pharmacy; Clinical Professor of Medicine, UC Davis School of Medicine.
John Fanikos
Michael Gulseth, Program Director for Anticoagulation Services, Sanford USD Medical Center
Dr. Gulseth is a well respected clinician and author in the area of anticoagulation management. He is the lead author and editor of the text, "Managing Anticoagulation Patients in the Hospital."
Maureen Smythe, PharmD, FCCP, Professor, Department of Pharmacy Practice, Wayne State University
I have established an expertise in inpatient anticoagulation through practice experience as well as through a practice based research program. I have spoken on the area of anticoagulation at numerous national meetings. I have published several papers addressing the controversies in heparin monitoring.
PROGRAM CHAIR:
Click the plus sign to see more detailed information about each speaker.
William Dager, PharmD, FCSHP, Pharmacist Specialist, University of California, Davis Medical Center
One of the major areas of patient care responsibilities for me has been the management of anticoagulation therapy, primarily in the inpatient setting. This has resulted in dozen of published manuscripts covering a wide number of related issues. I have also represented pharmacy on multi-disciplinary national events, and lectured on optimizing anticoagulation therapy. My practice setting has been highlighted in AJHP and by ACCP. Other related activities include serving as the chair of the editorial advisory board for The Annals of Pharmacotherapy panel on anticoagulation, and authored three chapters in the ASHP textbook on anticoagulation therapy edited by Michael Gulseth.
Other Academic Titles (without pay)
Clinical Professor of Pharmacy, UC San Francisco School of Pharmacy; Clinical Professor of Medicine, UC Davis School of Medicine.
LEARNER OUTCOMES:
Describe individualized approaches for initiating and monitoring anticoagulation therapy that includes identifying situations predisposing patients to adverse events.
Describe methods to establish and revise protocols for anticoagulation therapy.
Design approaches to anticoagulation management that includes switching between, overlapping, holding, or reversing anticoagulants.
Develop and communicate an anticoagulant management plan.
List strategies to document and support continued activities of an anticoagulation program.